Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New study looks at re-identification risks of hospital pharmacy prescription records

16.10.2009
A recent study led by Dr. Khaled El Emam, the Canada Research Chair in Electronic Health Information at the CHEO Research Institute, found that the information in hospital prescription records can quite easily re-identify patients.

Information on drug prescriptions are a highly sought after commodity. Pharmaceutical companies like to access this data to fine tune their marketing and sales efforts.

Many retail pharmacies in Canada sell their prescription records to commercial data aggregators who perform analyses for pharmaceutical companies; the potential privacy risk with such a practice is if the patients can be re-identified from this data. There is now more demand for this data from hospital pharmacies as well.

Dr. El Emam's study, titled "Evaluating the Risk of Re-identification of Patients from Hospital Prescription Records", demonstrates the importance of ensuring the proper de-identification of patient records. The study demonstrates a methodology for deciding which data to keep and which to de-identify, since hospital prescription data contains details such as where patients live and when they were admitted to the hospital.

"A meaningful risk analysis requires an understanding of the nature of plausible re-identification scenarios" explained Dr. El Emam "and is typically performed with a hospital's privacy officer to ensure that the risk to patient re-identification remains as low as possible."

The risk analysis performed in this study provided a way to anonymize the hospital prescription data to maintain the privacy of the patients, by generalizing and removing some variables such as postal codes, admission and discharge dates, or gender, before they are shared with outside companies.

Dr. El Emam's first article was published in the July-August issue of the Canadian Journal of Hospital Pharmacy and explains how he went about analyzing the data and finding the right combination of variables to ensure the privacy of hospital patients.

In a different study published earlier this year titled "Evaluating predictors of geographic area population size cutoffs to manage re-identification risk" Dr. El Emam performed the same risk analysis on the information released by retail pharmacies in Canada. The conclusion was that the risk of re-identifying patients from these prescription records was very small, and the privacy risks were consequently also small. This highlights the point that privacy risks in prescription records does depend on the source: retail vs. hospital.

This work was partially funded by the Ontario Centres of Excellence.

About Dr. Khaled El Emam: Dr. El Emam, Associate Professor, Faculty of Medicine and the School of Information Technology and Engineering, University of Ottawa, is a senior scientist and Principal Investigator at the Electronic Health Information laboratory at the CHEO Research Institute.

About the CHEO Research Institute: Established in 1984, the CHEO Research Institute coordinates the research activities of the Children's Hospital of Eastern Ontario (CHEO) and is one of the institutes associated with the University of Ottawa Teaching Hospitals. The Research Institute brings together health professionals from within CHEO to share their efforts in solving paediatric health problems. It also promotes collaborative research outside the hospital with partners from the immediate community, industry and the international scientific world.

Isabelle Mailloux | EurekAlert!
Further information:
http://www.cheori.org

More articles from Studies and Analyses:

nachricht Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung

nachricht Scientists reveal source of human heartbeat in 3-D
07.08.2017 | University of Manchester

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>